Beyond Corticosteroid Duration: Drug-Specific Pneumonitis Risk Should Inform Management of Immune Checkpoint Inhibitor Pneumonitis
- DOI
- 10.1093/ajrccm/aamag509
- Published
- 2026-09-25
- Container
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ajrccm/aamag509,
title = {Beyond Corticosteroid Duration: Drug-Specific Pneumonitis Risk Should Inform Management of Immune Checkpoint Inhibitor Pneumonitis},
author = {Mohammed I Danjuma and Anas Mahmoud Zayad and Ibrahim Yusuf Abubeker},
year = {2026},
journal = {American Journal of Respiratory and Critical Care Medicine},
doi = {10.1093/ajrccm/aamag509},
url = {https://doi.org/10.1093/ajrccm/aamag509}
}RIS
TY - JOUR TI - Beyond Corticosteroid Duration: Drug-Specific Pneumonitis Risk Should Inform Management of Immune Checkpoint Inhibitor Pneumonitis AU - Mohammed I Danjuma AU - Anas Mahmoud Zayad AU - Ibrahim Yusuf Abubeker PY - 2026 JO - American Journal of Respiratory and Critical Care Medicine DO - 10.1093/ajrccm/aamag509 UR - https://doi.org/10.1093/ajrccm/aamag509 ER -
APA
Danjuma, M. I., Zayad, A. M., & Abubeker, I. Y. (2026). Beyond Corticosteroid Duration: Drug-Specific Pneumonitis Risk Should Inform Management of Immune Checkpoint Inhibitor Pneumonitis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamag509
Source records
- crossref · retrieved 2026-09-26T02:21:29.197Z